|
|
|
Insider
Information: |
Hearne Michael S |
Relationship: |
Chief Financial Officer |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
2,620 |
|
Indirect Shares
|
12,767,435 |
|
|
Direct
Value |
$7,465,690 |
|
|
Indirect Value
|
$36,380,806,033 |
|
|
Total
Shares |
12,770,055 |
|
|
Total
Value |
$36,388,271,723 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
20
|
3
|
Stock
price went up :
|
10
|
0
|
Stock
price went down : |
10
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
Percentage
Gain/Loss : |
-17.1%
|
-97.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Odonate Therapeutics Inc |
ODT |
Chief Financial Officer |
2021-03-15 |
2,620 |
2021-11-19 |
12,767,435 |
Premium* |
|
La Jolla Pharmaceutical Co |
LJPC |
Chief Financial Officer |
2022-08-22 |
0 |
2022-08-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2020-06-02 |
4 |
B |
$4.88 |
$1,237,060 |
I/I |
253,553 |
8,333,898 |
1.99 |
% |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2020-06-03 |
4 |
B |
$4.90 |
$714,783 |
I/I |
145,764 |
8,479,662 |
1.99 |
% |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2020-06-04 |
4 |
B |
$4.94 |
$1,065,636 |
I/I |
215,812 |
8,695,474 |
1.99 |
% |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2020-08-12 |
4 |
B |
$3.47 |
$150,820 |
I/I |
43,513 |
8,738,987 |
1.99 |
% |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2020-08-13 |
4 |
B |
$3.65 |
$800,586 |
I/I |
219,465 |
8,958,452 |
1.99 |
% |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2020-08-14 |
4 |
B |
$3.88 |
$653,694 |
I/I |
168,669 |
9,127,121 |
1.99 |
% |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2020-09-04 |
4 |
B |
$3.82 |
$258,359 |
I/I |
67,552 |
9,194,673 |
1.99 |
% |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2020-09-08 |
4 |
B |
$3.90 |
$328,529 |
I/I |
84,152 |
9,278,825 |
1.99 |
% |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2020-09-09 |
4 |
B |
$4.01 |
$509,940 |
I/I |
126,665 |
9,405,490 |
1.99 |
% |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2020-10-15 |
4 |
A |
$3.32 |
$561 |
D/D |
169 |
169 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2020-10-30 |
4 |
A |
$2.89 |
$566 |
D/D |
196 |
365 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2020-11-13 |
4 |
A |
$3.98 |
$561 |
D/D |
141 |
506 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2020-11-30 |
4 |
A |
$4.23 |
$566 |
D/D |
134 |
640 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2020-12-15 |
4 |
A |
$3.83 |
$562 |
D/D |
147 |
787 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2020-12-31 |
4 |
A |
$3.30 |
$564 |
D/D |
171 |
958 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2020-12-31 |
4/A |
A |
$3.30 |
$5,435 |
D/D |
1,648 |
2,435 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-01-15 |
4/A |
A |
$4.55 |
$618 |
D/D |
136 |
2,571 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-01-15 |
4 |
A |
$4.55 |
$618 |
D/D |
136 |
1,094 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-01-29 |
4 |
A |
$5.20 |
$614 |
D/D |
118 |
2,689 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-02-12 |
4 |
A |
$5.70 |
$3,051 |
D/D |
535 |
3,224 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-02-26 |
4 |
A |
$4.45 |
$619 |
D/D |
139 |
3,363 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-03-15 |
4 |
A |
$4.85 |
$616 |
D/D |
127 |
3,490 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-03-31 |
4 |
A |
$3.60 |
$620 |
D/D |
172 |
3,662 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-04-15 |
4 |
A |
$3.55 |
$615 |
D/D |
173 |
3,835 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-04-30 |
4 |
A |
$3.77 |
$615 |
D/D |
163 |
3,572 |
0 |
- |
|
145 Records found
|
|
Page 1 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|